A study to compare the effectiveness of FreeStyle Libre Pro continuous glucose monitoring device against the conventional self monitoring of blood glucose levels through glucometers

Safety and Efficacy evaluation of Continuous Glucose Monitoring (Freestyle libre pro) versus self-monitoring of blood glucose in Diabetes Mellitus patients: A prospective randomized study - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/059160

Enrollment

Registered

2023-10-26

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Pharmacological intervention: After analyzing the data from CGM devices, intervention will be taken in form of including/excluding Oral hypoglycemic agents and/or Subcutaneous Insulin

Eligibility

Inclusion criteria

Inclusion criteria: (1)Type 2 Diabetes Mellitus patients taking more than or equal to 2 orally administered antihyperglycemic agents, (2)HbA1C more than or equal to 8%

Exclusion criteria

Exclusion criteria: (1)Type 1 Diabetes patients, Type 2 Diabetes Mellitus patients taking single orally administered antihyperglycemic agents or insulin (2)HbA1C less than 8% (3)Age less than 18 years, more than 65 years

Design outcomes

Primary

Measure	Time frame
Reduction in HbA1C valuesTimepoint: 3 months	—

Secondary

Measure	Time frame
Reduction in FBS/PPBS valuesTimepoint: 3 months	—

Countries

India

Contacts

Public ContactHarsh Patel

Dr DY Patil Medical College, Navi Mumbai

sppsmita9@gmail.com9821027742

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026